1. Prognostic impacts of extracranial metastasis on non‐small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database
- Author
-
Xulong Wang, Yixin Liu, Guizhen Qin, Yongchang Wei, Miao Wang, Tian Yang, Jun Zhang, Boyu Zhang, and Qiuji Wu
- Subjects
0301 basic medicine ,Adult ,Male ,Cancer Research ,Lung Neoplasms ,Adenocarcinoma of Lung ,computer.software_genre ,NSCLC ,lcsh:RC254-282 ,Metastasis ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Carcinoma, Non-Small-Cell Lung ,Surveillance, Epidemiology, and End Results ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Cumulative incidence ,brain metastasis ,Lung cancer ,Original Research ,Retrospective Studies ,Database ,business.industry ,Proportional hazards model ,Brain Neoplasms ,Bone metastasis ,Clinical Cancer Research ,Retrospective cohort study ,Middle Aged ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Prognosis ,Combined Modality Therapy ,Survival Rate ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Lymphatic Metastasis ,Carcinoma, Squamous Cell ,Carcinoma, Large Cell ,Female ,business ,computer ,Brain metastasis ,extracranial metastasis ,Follow-Up Studies ,SEER Program - Abstract
This study was designed to investigate the prognostic value of the number and sites of extracranial metastasis (ECM) in NSCLC patients with BM. NSCLC patients with BM from the Surveillance, Epidemiology, and End Results (SEER) database from 2010 to 2015 were enrolled in analysis. Patients from 2010 to 2013 were included in the training set and those from 2014 to 2015 in the validation set. ECM sites among different subtypes of NSCLC were compared by Chi‐square tests. Kaplan–Meier methods and Cox regression models were performed to analyze survival data. Competing‐risks analysis was used to predict cumulative incidence rates for CSS and non‐CSS cause. We included 5974 patients in the training cohort and 3561 patients in the validation cohort. Most (nearly 80%) NSCLC patients with BM showed 0–1 involved extracranial organ, with the most and least common ECM organ being bone and distant lymph nodes (DLNs) among all subtypes of NSCLC, respectively. The number of involved extracranial organs was an independent prognostic factor for patients with BM from NSCLC (p, Prognostic value of extracranial organ involvement the Surveillance, Epidemiology and End Results (SEER) database Tailored treatments would be reasonable for BM patients from NSCLC with different metastasis patterns.
- Published
- 2020